Losing weight was never
this easy

MensMD is designed for men aged 25–60 with a BMI of 27 or higher who want a clinically-supervised approach to sustainable weight loss. Best suited for men who've tried diet and exercise alone, those who want medical oversight throughout the journey, and those committed to integrated lifestyle changes alongside any medication. Not suitable for: men with active pancreatitis, history of medullary thyroid carcinoma or MEN-2, BMI under 27 (typically), severe gastrointestinal conditions, or active substance abuse.

Most programs fail for three reasons: they treat weight loss as a willpower problem (it's biological), they address only one lever (diet OR exercise OR medication), and they have no monitoring or adjustment system. Real, sustained weight loss requires understanding your biology through biomarkers, addressing multiple systems simultaneously, and adjusting the protocol as your body adapts. That's what makes MensMD different — we work all three pillars under physician supervision with continuous biomarker tracking.

We can prescribe Mounjaro (tirzepatide), Wegovy and Ozempic (semaglutide injectables), Rybelsus (oral semaglutide), Saxenda (liraglutide), and FDA-approved generic versions of semaglutide and liraglutide where available. Your physician matches the medication to your biomarkers, treatment goals, side effect profile, and cost preferences. Not everyone is prescribed medication — eligibility is determined by labs and clinical screening.

Clinical studies of GLP-1 medications show average weight loss of 12–15% of body weight over 12 months when combined with lifestyle support. In our program, this typically translates to 8–15 kg in the first 6 months for most participants who qualify for medication. Individual results depend on starting weight, biology, adherence, and protocol adjustments. Results are illustrative — not all participants achieve these outcomes.

There's no fixed end date. Most members continue for at least 6–12 months for substantial results, then transition to a maintenance protocol. You can cancel anytime with no long-term contract. Many members stay on for ongoing monitoring even after reaching their goal weight because the biomarker tracking continues to provide value.

Most common side effects (in ~30–40% of users initially): nausea, vomiting, diarrhea, constipation, and reduced appetite. These typically diminish over the first 4–8 weeks as your body adapts. Less common: fatigue, headaches, dizziness. Rare but serious: pancreatitis, gallbladder problems, kidney issues. Very rare: thyroid tumors (boxed warning). Our physicians monitor for and discuss all risks before prescribing, and we adjust dosing carefully to minimise side effects.

Throughout the program we monitor: total weight and body composition, waist circumference, energy levels, appetite patterns, sleep quality, habit consistency, and metabolic markers including HbA1c, fasting glucose, lipid panel, hsCRP (inflammation), liver and kidney function, and hormone levels (testosterone, thyroid). Quarterly comprehensive panels mean we catch issues early and adjust your protocol based on data, not guesswork.

Currently MensMD is a direct-to-consumer program not billed through insurance. This allows us to keep the experience streamlined and the physician–patient relationship uncomplicated by insurance constraints. Some GLP-1 medications may be partially reimbursable through certain insurance plans — we provide receipts and prescription details you can submit. We'll be transparent about all costs upfront with no hidden fees.

Yes. There are no contracts or commitment periods. You can pause or cancel your membership any month. If you're on medication, we'll guide you on safe tapering if appropriate. We want you in the program because it's working for you, not because you're locked in.

While weight loss is the primary outcome, members commonly report: improved energy and stamina, better sleep quality, sharper mental clarity, increased confidence, better metabolic markers (cholesterol, blood sugar), improved exercise capacity, and reduced inflammation. Many men also report psychological benefits — feeling more in control, less food-focused, and more present in their lives.

Most members notice changes in appetite and energy within the first 1–2 weeks on medication. Visible weight loss typically begins by week 3–4. Significant weight loss (5%+ body weight) usually occurs by month 2–3. Biomarker improvements often appear by the first quarterly retest. Your protocol is adjusted at each milestone to optimise results based on your data.